<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03776591</url>
  </required_header>
  <id_info>
    <org_study_id>REK 2015/2396</org_study_id>
    <nct_id>NCT03776591</nct_id>
  </id_info>
  <brief_title>Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer</brief_title>
  <acronym>D3/CME</acronym>
  <official_title>Open D3 Right Colectomy Compared to Laparoscopic CME Right Colectomy for Right Sided Colon Cancer; an Open Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haraldsplass Deaconess Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helse-Bergen HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Haraldsplass Deaconess Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary focus in this study is to investigate and improve the surgical technique. In&#xD;
      addition the collection of clinical data during diagnostic and follow up and the collection&#xD;
      of tumor and blood gives us the opportunity to investigate tumor biology and its relevance in&#xD;
      terms of determine appropriate treatment strategy both surgically and oncological and to&#xD;
      assess and predict treatment outcome.&#xD;
&#xD;
      The aim of this study is to compare short and long-term outcomes between open D3 and&#xD;
      laparoscopic CME (complete mesocolic excision) with CVL (central vascular ligation) right&#xD;
      colectomy for right-sided colon cancer. Our primary hypothesis is that laparoscopic surgery&#xD;
      improves quality of life by reducing pain, postoperative complications and thereby reduces&#xD;
      hospital stay and convalescence. On the other hand it is to prove non-inferiority of the&#xD;
      laparoscopic group compared to the open group by means of oncological outcome (survival,&#xD;
      recurrence). Secondary aim is to evaluate surgical quality by comparing actual vascular stump&#xD;
      length between the two groups by postoperative CT and compare number of lymph nodes removed&#xD;
      with the specimen. With the use of liquid biopsy we want to detect circulating tumor DNA&#xD;
      (ctDNA) and circulating tumor cells (CTCs) and evaluate their value as tumor markers by&#xD;
      comparing the prognostic and predictive value. The hypothesis is that ctDNA and CTCs are more&#xD;
      sensitive than standard parameters and imaging (CT CEA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, multi-center clinical study. The short term outcome, 2 and&#xD;
      5 year survival and mortality rates will be compared between the groups operated with open D3&#xD;
      resection at Haukeland University hospital and laparoscopic CME with CVL right hemicolectomy&#xD;
      at Haraldsplass Deaconess hospital. Computer generated block randomization will be used.&#xD;
&#xD;
      All patients ≤ 85 years with tumor localized in the right colon will be considered to&#xD;
      participate in the study. The patients will be summoned to the first consultation to the&#xD;
      hospital they are referred to. They will be informed of the study. A patient who meets the&#xD;
      inclusion criteria will be asked to participate in the study and sign the informed consent. A&#xD;
      patient who accepts will be assigned a sequential participant number and then referred to&#xD;
      open D3 or laparoscopic CME (right hemicolectomy) according to a pre-specified randomized&#xD;
      list of treatments.&#xD;
&#xD;
      All patients referred with right sided colon cancer in the inclusion period will be&#xD;
      registered, and the reason why some do not participate in the study will be documented.&#xD;
      Patients who decline to participate in the study will be assigned standard treatment in the&#xD;
      institution they are referred to.&#xD;
&#xD;
      Blood samples for analysis of ctDNA/CTCs will be collected preoperatively, 3-10th&#xD;
      postoperative day, at 3 months and at each check the next five years at six months intervals.&#xD;
      All sample times except the first postoperative control, correspond to the time of CEA and CT&#xD;
      in ordinary follow-up. Proteomic technology based analysis of tumor tissue&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Anticipated">September 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Surgical and general complications by Clavien-Dindo Classification og surgical complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical quality vascular resection</measure>
    <time_frame>6 months</time_frame>
    <description>Vascular stump length in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical quality lymph nodes</measure>
    <time_frame>6 months</time_frame>
    <description>Number of lymph nodes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient outcome general</measure>
    <time_frame>6 months</time_frame>
    <description>15D Health-related quality of life (HRQoL) preoperative and at 6 months. Scale 0-1. a higher score reflects a better HRQoL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient outcome bowel function</measure>
    <time_frame>6 months</time_frame>
    <description>Quality of life (LARS (low anterior resection syndrome) score preoperative and at 6 months. Scale 0-42, where 0 reflects no LARS and 30-42 major LARS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oncological outcome survival</measure>
    <time_frame>60 months</time_frame>
    <description>Survival in months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oncological outcome recurrence</measure>
    <time_frame>60 months</time_frame>
    <description>Time to recurrence in months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic significance of ctDNA</measure>
    <time_frame>60 months</time_frame>
    <description>copies/mL plasma or % fractional abundance (mutant/total ctDNA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic significance of CTCs</measure>
    <time_frame>60 months</time_frame>
    <description>CTC/ml blood</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Compare the D3 specimen with the CME specimen morphologically</measure>
    <time_frame>4 weeks</time_frame>
    <description>West classification</description>
  </other_outcome>
  <other_outcome>
    <measure>Operative parameters time</measure>
    <time_frame>1 day</time_frame>
    <description>Operating time in minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Operative parameters blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative blood loss in ml</description>
  </other_outcome>
  <other_outcome>
    <measure>Operative parameters bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>Incidents of bleeding from central vascular structures; yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperative parameters</measure>
    <time_frame>6 months</time_frame>
    <description>Incisional hernias; yes/no</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospitalization</measure>
    <time_frame>30 days</time_frame>
    <description>Total length of stay, including readmissions within 30 days</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Complication</condition>
  <condition>Quality of Life</condition>
  <condition>Surgical Procedure, Unspecified</condition>
  <condition>Lymph Node Metastases</condition>
  <condition>Circulating Tumor Cell</condition>
  <arm_group>
    <arm_group_label>Open D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right colectomy Open surgery Central lymphadenectomy and vascular ligation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic CME with CVL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Right colectomy Laparoscopic surgery Central lymphadenectomy and vascular ligation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open surgery</intervention_name>
    <arm_group_label>Open D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right colectomy</intervention_name>
    <arm_group_label>Laparoscopic CME with CVL</arm_group_label>
    <arm_group_label>Open D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic surgery</intervention_name>
    <arm_group_label>Laparoscopic CME with CVL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Central lymphadenectomy and vascular ligation</intervention_name>
    <arm_group_label>Laparoscopic CME with CVL</arm_group_label>
    <arm_group_label>Open D3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Patients with malignant tumor of the right colon (cecum, ascending colon, right&#xD;
             flexure and right transverse) at CT, colonoscopy.&#xD;
&#xD;
               -  Patients medically cleared by anesthesiologist for general anesthesia and&#xD;
                  oncological radical resection&#xD;
&#xD;
               -  Patients ≤ 85 years&#xD;
&#xD;
               -  Signed informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Patients with recurrent cancer after previous surgery&#xD;
&#xD;
               -  Patients with synchronous distant metastasis&#xD;
&#xD;
               -  Patients with ongoing oncological treatment due to other cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristin B. Lygre, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Haraldsplass Deaconess Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristin B Lygre, M.D</last_name>
    <phone>004755978500</phone>
    <email>kristin.bentung.lygre@haraldsplass.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Frank Pfeffer, Ph.D</last_name>
    <phone>004755975000</phone>
    <email>frank.pfeffer@helse-bergen.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Haraldsplass</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristin B Lygre, M.D</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 6, 2018</study_first_submitted>
  <study_first_submitted_qc>December 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2018</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Haraldsplass Deaconess Hospital</investigator_affiliation>
    <investigator_full_name>Kristin Bentung Lygre</investigator_full_name>
    <investigator_title>Consultant Doctor</investigator_title>
  </responsible_party>
  <keyword>D3 lymphadenectomy</keyword>
  <keyword>Right-sided</keyword>
  <keyword>Colon cancer</keyword>
  <keyword>Complications</keyword>
  <keyword>Circulating tumor cells</keyword>
  <keyword>Circulating DNA (cDNA)</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>Complete mesocolic excision</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Neoplastic Cells, Circulating</mesh_term>
    <mesh_term>Lymphatic Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

